Former President & CEO of GPC Biotech, NASDAQ listed oncology company. He built the company from a pre-clinical stage to a phase 3 clinical oncology company. Prior to that VP Oncology drug discovery at Bristol-Myers Squibb. Senior Faculty positions at Harvard Medical School, Massachusetts General Hospital and Princeton Univer
Current role